Zacks Investment Research on MSN
Will the Orbital Acquisition Strengthen BMY's Cell Therapy Portfolio?
Bristol Myers BMY recently announced that it will acquire privately held biotechnology company Orbital Therapeutics for $1.5 ...
Matthew Taylor likened his recently published work alongside doctoral student Gary Dunn to kicking over a rock. Once the ...
Using NISTCHO means people can test the reproducibility of experiments in different labs and with different off-the-shelf media.
In a new study published in Nature Communications titled, “The reference genome of the human diploid cell line RPE-1,” researchers from University of Rome La Sapienza have produced the first reference ...
4don MSN
Tiny surface shapes steer cancer cells, paving the way for better lab tests and safer implants
Griffith University researchers have shown that the shape and surface chemistry of microscopic "re-entrant" structures—tiny overhanging caps arranged like mushroom tops—can tune how cancer cells stick ...
In this edition of the biotech bi-weekly, product launches enhancing microbial analysis and biologics development and ...
Indian solar manufacturer Premier Energies has commissioned a 1.2GW TOPCon solar cell manufacturing line at Fab City, Hyderabad, Telangana. According to the firm, the plant will achieve over 25% cell ...
Websol Energy System approved the addition of 4 GW of solar cell and module manufacturing capacity with a total investment of INR 30 billion (€333 million/$364 million). The company said the new cell ...
Premier Energies has commissioned a new 1.2 GW TOPCon solar cell manufacturing line at Fab City, Hyderabad. The facility delivers cell efficiencies above 25% with advanced 16-busbar architecture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results